Special Issue "Antimicrobial Resistance during the COVID-19 Outbreak"

A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Mechanism and Evolution of Antibiotic Resistance".

Deadline for manuscript submissions: 1 October 2021.

Special Issue Editors

Dr. Timothy Rawson
E-Mail Website
Guest Editor
Faculty of Medicine, Department of Infectious Disease, Imperial College London, London, UK
Interests: antimicrobial stewardship; dose optimisation; machine learning; biosensors
Dr. Luke S. P. Moore
E-Mail Website
Co-Guest Editor
Faculty of Medicine, Department of Infectious Disease, Imperial College London, London, UK
Interests: antimicrobial stewardship; antimicrobial resistance; clinical decision support; diagnostics
Prof. Alison Holmes
E-Mail Website
Co-Guest Editor
Faculty of Medicine, Department of Infectious Disease, Imperial College London, London, UK
Interests: antimicrobial stewardship; antimicrobial resistance; epidemiology

Special Issue Information

Dear Colleagues,

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent pandemic has placed an immense strain on healthcare systems worldwide. The challenges posed by the diagnosis and management of coronavirus disease 2019 (COVID-19) together with concerns regarding associated bacterial and fungal infection have promoted the extensive use of antimicrobials in acute care. In contrast, in the community, we have observed a reduction of antimicrobial use. The impact that the COVID-19 pandemic will have on antimicrobial resistance in the long term remains unknown.

We are pleased to invite you to contribute to this Special Issue of Antibiotics. The aim of this Special Issue is to provide insights into the impact of COVID-19 on antimicrobial use and antimicrobial resistance. We also aim to highlight and discuss specific interventions that have been developed to address inappropriate antimicrobial use and antimicrobial resistance during the pandemic.

Dr. Timothy Rawson
Dr. Luke S. P. Moore
Prof. Alison Holmes
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antimicrobial stewardship
  • antimicrobial resistance
  • COVID-19
  • SARS-CoV-2
  • diagnostics
  • interventions
  • co-infection
  • healthcare-associated infection

Published Papers

This special issue is now open for submission.
Back to TopTop